Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies
- PMID: 23061743
- DOI: 10.3109/13625187.2012.715357
Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies
Abstract
Background and objectives: It has been suggested that taking oral contraceptives (OCs) may increase breast cancer incidence. However, data in this regard are inconsistent. We performed this meta-analysis to estimate the association between OC use and breast cancer risk.
Methods: Prospective cohort studies on OC use and breast cancer risk were identified by searching databases from the period 1960 to 2012. Results from individual studies were synthetically combined using STATA 11 software.
Results: A total of 13 prospective cohort studies were included in our meta-analysis, involving 11,722 cases and 859,894 participants. The combined relative risk (RR) of breast cancer for ever- compared with never-OC users was 1.08 (95% confidence interval [CI]: 0.99-1.17). Dose-response analysis based on five eligible studies showed that every ten-years' increment of OC use was associated with a significant 14% (95% CI: 1.05-1.23) rise in breast cancer risk. Little evidence of publication bias was found.
Conclusions: This meta-analysis provides evidence of a non-significant increase in breast cancer risk associated with ever OC use, but the risk for long-term OC users is significantly greater. However, the latter finding is based on only a limited number of studies.
Similar articles
-
Breast cancer among young U.S. women in relation to oral contraceptive use.J Natl Cancer Inst. 1994 Apr 6;86(7):505-14. doi: 10.1093/jnci/86.7.505. J Natl Cancer Inst. 1994. PMID: 8133534
-
Oral contraceptive agents and breast cancer: a population-based case-control study.Med J Aust. 1988 Nov 21;149(10):520-6. doi: 10.5694/j.1326-5377.1988.tb120759.x. Med J Aust. 1988. PMID: 3185321
-
Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway.Lancet. 1986 Sep 20;2(8508):650-4. doi: 10.1016/s0140-6736(86)90166-2. Lancet. 1986. PMID: 2876135
-
Oral contraceptives and breast cancer: review of the epidemiologic literature.Contraception. 1991 Jun;43(6):597-642. doi: 10.1016/0010-7824(91)90006-2. Contraception. 1991. PMID: 1868735 Review.
-
Oral contraceptives and gynecologic cancer: an update for the 1990s.Am J Obstet Gynecol. 1992 Oct;167(4 Pt 2):1171-6. doi: 10.1016/s0002-9378(12)90407-x. Am J Obstet Gynecol. 1992. PMID: 1415442 Review.
Cited by
-
Association between MTHFR gene 1298A>C polymorphism and breast cancer susceptibility: a meta-analysis based on 38 case-control studies with 40,985 subjects.World J Surg Oncol. 2016 Aug 27;14(1):230. doi: 10.1186/s12957-016-0978-2. World J Surg Oncol. 2016. PMID: 27568010 Free PMC article.
-
Cancer Progress and Priorities: Breast Cancer.Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):822-844. doi: 10.1158/1055-9965.EPI-20-1193. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33947744 Free PMC article. Review. No abstract available.
-
Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study.EBioMedicine. 2016 May;7:73-9. doi: 10.1016/j.ebiom.2016.03.018. Epub 2016 Mar 14. EBioMedicine. 2016. PMID: 27322460 Free PMC article.
-
Associations of Oral Contraceptives with Mammographic Breast Density in Premenopausal Women.Cancer Epidemiol Biomarkers Prev. 2022 Feb;31(2):436-442. doi: 10.1158/1055-9965.EPI-21-0853. Epub 2021 Dec 3. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 34862209 Free PMC article.
-
Lobular breast cancer: incidence and genetic and non-genetic risk factors.Breast Cancer Res. 2015 Mar 13;17:37. doi: 10.1186/s13058-015-0546-7. Breast Cancer Res. 2015. PMID: 25848941 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
